{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:44:36Z","timestamp":1787319876373,"version":"build-2736575974"},"reference-count":106,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,8,21]],"date-time":"2024-08-21T00:00:00Z","timestamp":1724198400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,21]],"date-time":"2024-08-21T00:00:00Z","timestamp":1724198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001840","name":"Icelandic Centre for Research","doi-asserted-by":"publisher","award":["206692-051"],"award-info":[{"award-number":["206692-051"]}],"id":[{"id":"10.13039\/501100001840","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["1K08AG068604"],"award-info":[{"award-number":["1K08AG068604"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["U01AG061357"],"award-info":[{"award-number":["U01AG061357"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["N01-AG-12100"],"award-info":[{"award-number":["N01-AG-12100"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["HHSN271201200022C"],"award-info":[{"award-number":["HHSN271201200022C"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["1R01AG065596"],"award-info":[{"award-number":["1R01AG065596"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Ministry of Economy and Competitiveness | Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["Sara Borrell (CD22\/00125)"],"award-info":[{"award-number":["Sara Borrell (CD22\/00125)"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["115975"],"award-info":[{"award-number":["115975"]}],"id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["115985"],"award-info":[{"award-number":["115985"]}],"id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012331","name":"Agentschap Innoveren en Ondernemen","doi-asserted-by":"publisher","award":["N\u00ba PR067\/21"],"award-info":[{"award-number":["N\u00ba PR067\/21"]}],"id":[{"id":"10.13039\/100012331","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Aging"],"DOI":"10.1038\/s43587-024-00693-1","type":"journal-article","created":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T11:06:41Z","timestamp":1724324801000},"page":"1446-1464","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Serum proteomics reveal APOE-\u03b54-dependent and APOE-\u03b54-independent protein signatures in Alzheimer\u2019s disease"],"prefix":"10.1038","volume":"4","author":[{"given":"Elisabet A.","family":"Frick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9982-0524","authenticated-orcid":false,"given":"Valur","family":"Emilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9158-0087","authenticated-orcid":false,"given":"Thorarinn","family":"Jonmundsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2386-5934","authenticated-orcid":false,"given":"Anna E.","family":"Steindorsdottir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0604-2944","authenticated-orcid":false,"given":"Erik C. B.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1191-5893","authenticated-orcid":false,"given":"Raquel","family":"Puerta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2947-7606","authenticated-orcid":false,"given":"Eric B.","family":"Dammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1384-941X","authenticated-orcid":false,"given":"Anantharaman","family":"Shantaraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Cano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2617-3009","authenticated-orcid":false,"given":"Merc\u00e8","family":"Boada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergi","family":"Valero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0125-5403","authenticated-orcid":false,"given":"Pablo","family":"Garc\u00eda-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7661-4872","authenticated-orcid":false,"given":"Elias F.","family":"Gudmundsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Gudjonsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4733-414X","authenticated-orcid":false,"given":"Rebecca","family":"Pitts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8397-2168","authenticated-orcid":false,"given":"Xiazi","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Finkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7222-9160","authenticated-orcid":false,"given":"Joseph J.","family":"Loureiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9865-0494","authenticated-orcid":false,"given":"Anthony P.","family":"Orth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4507-624X","authenticated-orcid":false,"given":"Nicholas T.","family":"Seyfried","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3153-502X","authenticated-orcid":false,"given":"Allan I.","family":"Levey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2633-2495","authenticated-orcid":false,"given":"Agustin","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7998-5433","authenticated-orcid":false,"given":"Thor","family":"Aspelund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5130-8417","authenticated-orcid":false,"given":"Lori L.","family":"Jennings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3238-7612","authenticated-orcid":false,"given":"Lenore J.","family":"Launer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7459-1603","authenticated-orcid":false,"given":"Valborg","family":"Gudmundsdottir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5696-0084","authenticated-orcid":false,"given":"Vilmundur","family":"Gudnason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,21]]},"reference":[{"key":"693_CR1","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1001\/archpsyc.63.2.168","volume":"63","author":"M Gatz","year":"2006","unstructured":"Gatz, M. et al. Role of genes and environments for explaining Alzheimer disease. Arch. Gen. Psychiatry 63, 168\u2013174 (2006).","journal-title":"Arch. Gen. Psychiatry"},{"key":"693_CR2","doi-asserted-by":"crossref","first-page":"e512","DOI":"10.1212\/NXG.0000000000000512","volume":"6","author":"C Reitz","year":"2020","unstructured":"Reitz, C., Rogaeva, E. & Beecham, G. W. Late-onset vs nonmendelian early-onset Alzheimer disease: a distinction without a difference? Neurol. Genet. 6, e512 (2020).","journal-title":"Neurol. Genet."},{"key":"693_CR3","doi-asserted-by":"crossref","first-page":"1966\u20131975","DOI":"10.1002\/alz.12362","volume":"17","author":"KB Rajan","year":"2021","unstructured":"Rajan, K. B. et al. Population estimate of people with clinical AD and mild cognitive impairment in the United States (2020\u20132060). Alzheimers Dement. 17, 1966\u20131975 (2021).","journal-title":"Alzheimers Dement."},{"key":"693_CR4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2023","unstructured":"van Dyck, C. H. et al. Lecanemab in early Alzheimer\u2019s disease. N. Engl. J. Med. 388, 9\u201321 (2023).","journal-title":"N. Engl. J. Med."},{"key":"693_CR5","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa2100708","volume":"384","author":"MA Mintun","year":"2021","unstructured":"Mintun, M. A. et al. Donanemab in early Alzheimer\u2019s disease. N. Engl. J. Med. 384, 1691\u20131704 (2021).","journal-title":"N. Engl. J. Med."},{"key":"693_CR6","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.3233\/JAD-140669","volume":"49","author":"M Sattlecker","year":"2016","unstructured":"Sattlecker, M. et al. Longitudinal protein changes in blood plasma associated with the rate of cognitive decline in Alzheimer\u2019s disease. J. Alzheimers Dis. 49, 1105\u20131114 (2016).","journal-title":"J. Alzheimers Dis."},{"key":"693_CR7","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3233\/JAD-130380","volume":"38","author":"SJ Kiddle","year":"2014","unstructured":"Kiddle, S. J. et al. Candidate blood proteome markers of Alzheimer\u2019s disease onset and progression: a systematic review and replication study. J. Alzheimers Dis. 38, 515\u2013531 (2014).","journal-title":"J. Alzheimers Dis."},{"key":"693_CR8","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.jalz.2013.09.016","volume":"10","author":"M Sattlecker","year":"2014","unstructured":"Sattlecker, M. et al. Alzheimer\u2019s disease biomarker discovery using SOMAscan multiplexed protein technology. Alzheimers Dement. 10, 724\u2013734 (2014).","journal-title":"Alzheimers Dement."},{"key":"693_CR9","first-page":"1077\u20131081","volume":"67","author":"SE O\u2019Bryant","year":"2010","unstructured":"O\u2019Bryant, S. E. et al. A serum protein-based algorithm for the detection of Alzheimer\u2019s disease. Arch. Neurol. 67, 1077\u20131081 (2010).","journal-title":"Arch. Neurol."},{"key":"693_CR10","doi-asserted-by":"crossref","first-page":"4902","DOI":"10.1021\/pr200270z","volume":"10","author":"L Ijsselstijn","year":"2011","unstructured":"Ijsselstijn, L. et al. Serum levels of pregnancy zone protein are elevated in presymptomatic Alzheimer\u2019s disease. J. Proteome Res. 10, 4902\u20134910 (2011).","journal-title":"J. Proteome Res."},{"key":"693_CR11","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/nm1653","volume":"13","author":"S Ray","year":"2007","unstructured":"Ray, S. et al. Classification and prediction of clinical Alzheimer\u2019s diagnosis based on plasma signaling proteins. Nat. Med. 13, 1359\u20131362 (2007).","journal-title":"Nat. Med."},{"key":"693_CR12","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s00702-012-0781-3","volume":"119","author":"AW Henkel","year":"2012","unstructured":"Henkel, A. W. et al. Multidimensional plasma protein separation technique for identification of potential Alzheimer\u2019s disease plasma biomarkers: a pilot study. J. Neural Transm. 119, 779\u2013788 (2012).","journal-title":"J. Neural Transm."},{"key":"693_CR13","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/S0006-291X(02)00420-5","volume":"293","author":"J Choi","year":"2002","unstructured":"Choi, J., Malakowsky, C. A., Talent, J. M., Conrad, C. C. & Gracy, R. W. Identification of oxidized plasma proteins in Alzheimer\u2019s disease. Biochem. Biophys. Res. Commun. 293, 1566\u20131570 (2002).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"693_CR14","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/prca.200780101","volume":"2","author":"P Cutler","year":"2008","unstructured":"Cutler, P. et al. Proteomic identification and early validation of complement 1 inhibitor and pigment epithelium-derived factor: two novel biomarkers of Alzheimer\u2019s disease in human plasma. Proteomics Clin. Appl. 2, 467\u2013477 (2008).","journal-title":"Proteomics Clin. Appl."},{"key":"693_CR15","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1093\/brain\/awl279","volume":"129","author":"A Hye","year":"2006","unstructured":"Hye, A. et al. Proteome-based plasma biomarkers for Alzheimer\u2019s disease. Brain 129, 3042\u20133050 (2006).","journal-title":"Brain"},{"key":"693_CR16","doi-asserted-by":"crossref","first-page":"1318\u20131325","DOI":"10.1001\/archneurol.2012.1282","volume":"69","author":"JD Doecke","year":"2012","unstructured":"Doecke, J. D. et al. Blood-based protein biomarkers for diagnosis of Alzheimer disease. Arch. Neurol. 69, 1318\u20131325 (2012).","journal-title":"Arch. Neurol."},{"key":"693_CR17","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/s43587-021-00064-0","volume":"1","author":"KA Walker","year":"2021","unstructured":"Walker, K. A. et al. Large-scale plasma proteomic analysis identifies proteins and pathways associated with dementia risk. Nat. Aging 1, 473\u2013489 (2021).","journal-title":"Nat. Aging"},{"key":"693_CR18","unstructured":"Bellenguez, C. et al. New insights into the genetic etiology of Alzheimer\u2019s disease and related dementias. Nat. Genet. 54, 412\u2013436 (2022)."},{"key":"693_CR19","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13024-021-00505-9","volume":"17","author":"M Khani","year":"2022","unstructured":"Khani, M., Gibbons, E., Bras, J. & Guerreiro, R. Challenge accepted: uncovering the role of rare genetic variants in Alzheimer\u2019s disease. Mol. Neurodegener. 17, 3 (2022).","journal-title":"Mol. Neurodegener."},{"key":"693_CR20","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1136\/jnnp.65.1.103","volume":"65","author":"GB Frisoni","year":"1998","unstructured":"Frisoni, G. B. et al. The prevalence of apoE-\u03b54 in Alzheimer\u2019s disease is age dependent. J. Neurol. Neurosurg. Psychiatry 65, 103 (1998).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"693_CR21","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13195-020-00740-0","volume":"13","author":"A Gharbi-Meliani","year":"2021","unstructured":"Gharbi-Meliani, A. et al. The association of APOE \u03b54 with cognitive function over the adult life course and incidence of dementia: 20 years follow-up of the Whitehall II study. Alzheimers Res. Ther. 13, 5 (2021).","journal-title":"Alzheimers Res. Ther."},{"key":"693_CR22","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","volume":"261","author":"EH Corder","year":"1993","unstructured":"Corder, E. H. et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families. Science 261, 921\u2013923 (1993).","journal-title":"Science"},{"key":"693_CR23","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/s41467-021-27850-z","volume":"13","author":"A Gudjonsson","year":"2022","unstructured":"Gudjonsson, A. et al. A genome-wide association study of serum proteins reveals shared loci with common diseases. Nat. Commun. 13, 480 (2022).","journal-title":"Nat. Commun."},{"key":"693_CR24","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41586-018-0175-2","volume":"558","author":"BB Sun","year":"2018","unstructured":"Sun, B. B. et al. Genomic atlas of the human plasma proteome. Nature 558, 73\u201379 (2018).","journal-title":"Nature"},{"key":"693_CR25","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1126\/science.aaq1327","volume":"361","author":"V Emilsson","year":"2018","unstructured":"Emilsson, V. et al. Co-regulatory networks of human serum proteins link genetics to disease. Science 361, 769\u2013773 (2018).","journal-title":"Science"},{"key":"693_CR26","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/s41467-022-28081-6","volume":"13","author":"V Emilsson","year":"2022","unstructured":"Emilsson, V. et al. Coding and regulatory variants are associated with serum protein levels and disease. Nat. Commun. 13, 481 (2022).","journal-title":"Nat. Commun."},{"key":"693_CR27","doi-asserted-by":"publisher","unstructured":"Cruchaga, C. et al. Proteogenomic analysis of human cerebrospinal fluid identifies neurologically relevant regulation and informs causal proteins for Alzheimer\u2019s disease. Preprint at Research Square https:\/\/doi.org\/10.21203\/rs.3.rs-2814616\/v1 (2023).","DOI":"10.21203\/rs.3.rs-2814616\/v1"},{"key":"693_CR28","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/s41593-021-00886-6","volume":"24","author":"C Yang","year":"2021","unstructured":"Yang, C. et al. Genomic atlas of the proteome from brain, CSF and plasma prioritizes proteins implicated in neurological disorders. Nat. Neurosci. 24, 1302\u20131312 (2021).","journal-title":"Nat. Neurosci."},{"key":"693_CR29","doi-asserted-by":"crossref","first-page":"1076\u20131087","DOI":"10.1093\/aje\/kwk115","volume":"165","author":"TB Harris","year":"2007","unstructured":"Harris, T. B. et al. Age, Gene\/Environment Susceptibility-Reykjavik Study: multidisciplinary applied phenomics. Am. J. Epidemiol. 165, 1076\u20131087 (2007).","journal-title":"Am. J. Epidemiol."},{"key":"693_CR30","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13195-023-01221-w","volume":"15","author":"M Malek-Ahmadi","year":"2023","unstructured":"Malek-Ahmadi, M. et al. Plasma NfL is associated with the APOE \u03b54 allele, brain imaging measurements of neurodegeneration, and lower recall memory scores in cognitively unimpaired late-middle-aged and older adults. Alzheimers Res. Ther. 15, 74 (2023).","journal-title":"Alzheimers Res. Ther."},{"key":"693_CR31","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcac045","volume":"4","author":"MM Budelier","year":"2022","unstructured":"Budelier, M. M. et al. A map of neurofilament light chain species in brain and cerebrospinal fluid and alterations in Alzheimer\u2019s disease. Brain Commun. 4, fcac045 (2022).","journal-title":"Brain Commun."},{"key":"693_CR32","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nmeth.4083","volume":"14","author":"T Li","year":"2016","unstructured":"Li, T. et al. A scored human protein\u2013protein interaction network to catalyze genomic interpretation. Nat. Methods 14, 61\u201364 (2016).","journal-title":"Nat. Methods"},{"key":"693_CR33","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms6068","volume":"5","author":"I Postmus","year":"2014","unstructured":"Postmus, I. et al. Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins. Nat. Commun. 5, 5068 (2014).","journal-title":"Nat. Commun."},{"key":"693_CR34","doi-asserted-by":"crossref","first-page":"108352","DOI":"10.1016\/j.neuropharm.2020.108352","volume":"190","author":"G Marucci","year":"2021","unstructured":"Marucci, G. et al. Efficacy of acetylcholinesterase inhibitors in Alzheimer\u2019s disease. Neuropharmacology 190, 108352 (2021).","journal-title":"Neuropharmacology"},{"key":"693_CR35","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1038\/s41588-021-00978-w","volume":"53","author":"E Ferkingstad","year":"2021","unstructured":"Ferkingstad, E. et al. Large-scale integration of the plasma proteome with genetics and disease. Nat. Genet. 53, 1712\u20131721 (2021).","journal-title":"Nat. Genet."},{"key":"693_CR36","doi-asserted-by":"crossref","first-page":"eadn3504","DOI":"10.1126\/scitranslmed.adn3504","volume":"16","author":"EB Dammer","year":"2024","unstructured":"Dammer, E. B. et al. Proteomic analysis of Alzheimer\u2019s disease cerebrospinal fluid reveals alterations associated with APOE \u03b54 and atomoxetine treatment. Sci. Transl. Med. 16, eadn3504 (2024).","journal-title":"Sci. Transl. Med."},{"key":"693_CR37","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41593-021-00999-y","volume":"25","author":"ECB Johnson","year":"2022","unstructured":"Johnson, E. C. B. et al. Large-scale deep multi-layer analysis of Alzheimer\u2019s disease brain reveals strong proteomic disease-related changes not observed at the RNA level. Nat. Neurosci. 25, 213\u2013225 (2022).","journal-title":"Nat. Neurosci."},{"key":"693_CR38","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13195-022-01113-5","volume":"14","author":"EB Dammer","year":"2022","unstructured":"Dammer, E. B. et al. Multi-platform proteomic analysis of Alzheimer\u2019s disease cerebrospinal fluid and plasma reveals network biomarkers associated with proteostasis and the matrisome. Alzheimers Res. Ther. 14, 174 (2022).","journal-title":"Alzheimers Res. Ther."},{"key":"693_CR39","first-page":"14","volume":"7\u20138","author":"T Porter","year":"2018","unstructured":"Porter, T. et al. Cognitive gene risk profile for the prediction of cognitive decline in presymptomatic Alzheimer\u2019s disease. Pers. Med. Psychiatry 7\u20138, 14\u201320 (2018).","journal-title":"Pers. Med. Psychiatry"},{"key":"693_CR40","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12014-020-09285-8","volume":"17","author":"M Zhou","year":"2020","unstructured":"Zhou, M. et al. Targeted mass spectrometry to quantify brain-derived cerebrospinal fluid biomarkers in Alzheimer\u2019s disease. Clin. Proteomics 17, 19 (2020).","journal-title":"Clin. Proteomics"},{"key":"693_CR41","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/cdd.2008.191","volume":"16","author":"FC Louren\u00e7o","year":"2009","unstructured":"Louren\u00e7o, F. C. et al. Netrin-1 interacts with amyloid precursor protein and regulates amyloid-\u03b2 production. Cell Death Differ. 16, 655\u2013663 (2009).","journal-title":"Cell Death Differ."},{"key":"693_CR42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuron.2016.06.030","volume":"91","author":"H Zetterberg","year":"2016","unstructured":"Zetterberg, H. Neurofilament light: a dynamic cross-disease fluid biomarker for neurodegeneration. Neuron 91, 1\u20133 (2016).","journal-title":"Neuron"},{"key":"693_CR43","doi-asserted-by":"crossref","first-page":"eabg9922","DOI":"10.1126\/scitranslmed.abg9922","volume":"13","author":"NSN Graham","year":"2021","unstructured":"Graham, N. S. N. et al. Axonal marker neurofilament light predicts long-term outcomes and progressive neurodegeneration after traumatic brain injury. Sci. Transl. Med. 13, eabg9922 (2021).","journal-title":"Sci. Transl. Med."},{"key":"693_CR44","unstructured":"Wolters, F. et al. Von Willebrand factor and the risk of dementia: a population-based study. Neurology 8, 5474 (2018)."},{"key":"693_CR45","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1038\/s41591-023-02476-4","volume":"29","author":"ECB Johnson","year":"2023","unstructured":"Johnson, E. C. B. et al. Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer\u2019s disease. Nat. Med. 29, 1979\u20131988 (2023).","journal-title":"Nat. Med."},{"key":"693_CR46","doi-asserted-by":"crossref","first-page":"612\u2013624","DOI":"10.1002\/alz.12419","volume":"18","author":"JV Lindbohm","year":"2022","unstructured":"Lindbohm, J. V. et al. Plasma proteins, cognitive decline, and 20\u2010year risk of dementia in the Whitehall II and Atherosclerosis Risk in Communities studies. Alzheimers Dement. 18, 612\u2013624 (2022).","journal-title":"Alzheimers Dement."},{"key":"693_CR47","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/s41586-023-06563-x","volume":"622","author":"GH Eldjarn","year":"2023","unstructured":"Eldjarn, G. H. et al. Large-scale plasma proteomics comparisons through genetics and disease associations. Nature 622, 348\u2013358 (2023).","journal-title":"Nature"},{"key":"693_CR48","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/s43587-023-00565-0","volume":"4","author":"Y Guo","year":"2024","unstructured":"Guo, Y. et al. Plasma proteomic profiles predict future dementia in healthy adults. Nat. Aging 4, 247\u2013260 (2024).","journal-title":"Nat. Aging"},{"key":"693_CR49","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13023","volume":"18","author":"P Sebastiani","year":"2019","unstructured":"Sebastiani, P. et al. A serum protein signature of APOE genotypes in centenarians. Aging Cell 18, e13023 (2019).","journal-title":"Aging Cell"},{"key":"693_CR50","doi-asserted-by":"crossref","first-page":"D1005","DOI":"10.1093\/nar\/gky1120","volume":"47","author":"A Buniello","year":"2019","unstructured":"Buniello, A. et al. The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019. Nucleic Acids Res. 47, D1005\u2013D1012 (2019).","journal-title":"Nucleic Acids Res."},{"key":"693_CR51","first-page":"108\u2013117","volume":"21","author":"G Jun","year":"2016","unstructured":"Jun, G. et al. A novel Alzheimer disease locus located near the gene encoding tau protein. Mol. Psychiatry 21, 108\u2013117 (2016).","journal-title":"Mol. Psychiatry"},{"key":"693_CR52","volume":"11","author":"H-H Chen","year":"2021","unstructured":"Chen, H.-H. et al. Genetically regulated expression in late-onset Alzheimer\u2019s disease implicates risk genes within known and novel loci. Transl. Psychiatry 11, 618 (2021).","journal-title":"Transl. Psychiatry"},{"key":"693_CR53","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41588-022-01016-z","volume":"54","author":"A Okbay","year":"2022","unstructured":"Okbay, A. et al. Polygenic prediction of educational attainment within and between families from genome-wide association analyses in 3 million individuals. Nat. Genet. 54, 437\u2013449 (2022).","journal-title":"Nat. Genet."},{"key":"693_CR54","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41593-022-01042-4","volume":"25","author":"RM Brouwer","year":"2022","unstructured":"Brouwer, R. M. et al. Genetic variants associated with longitudinal changes in brain structure across the lifespan. Nat. Neurosci. 25, 421\u2013432 (2022).","journal-title":"Nat. Neurosci."},{"key":"693_CR55","unstructured":"Davies, G. et al. Study of 300,486 individuals identifies 148 independent genetic loci influencing general cognitive function. Nat. Commun. 9, 2098 (2018)."},{"key":"693_CR56","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.neurobiolaging.2020.04.025","volume":"93","author":"H Wang","year":"2020","unstructured":"Wang, H. et al. Genome-wide interaction analysis of pathological hallmarks in Alzheimer\u2019s disease. Neurobiol. Aging 93, 61\u201368 (2020).","journal-title":"Neurobiol. Aging"},{"key":"693_CR57","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.atherosclerosis.2016.10.037","volume":"255","author":"KL Rasmussen","year":"2016","unstructured":"Rasmussen, K. L. Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: a review. Atherosclerosis 255, 145\u2013155 (2016).","journal-title":"Atherosclerosis"},{"key":"693_CR58","doi-asserted-by":"crossref","first-page":"fcac070","DOI":"10.1093\/braincomms\/fcac070","volume":"4","author":"CA Leckey","year":"2022","unstructured":"Leckey, C. A. & Zetterberg, H. Neurofilament light chain: defining the analyte. Brain Commun. 4, fcac070 (2022).","journal-title":"Brain Commun."},{"key":"693_CR59","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.bpsgos.2022.04.005","volume":"3","author":"A Tin","year":"2022","unstructured":"Tin, A. et al. Proteomic analysis identifies circulating proteins associated with plasma amyloid \u03b2 and incident dementia. Biol. Psychiatry Glob. Open Sci. 3, 490\u2013499 (2022).","journal-title":"Biol. Psychiatry Glob. Open Sci."},{"key":"693_CR60","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1126\/science.2949367","volume":"235","author":"RE Tanzi","year":"1987","unstructured":"Tanzi, R. E. et al. Amyloid \u03b2 protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. Science 235, 880\u2013884 (1987).","journal-title":"Science"},{"key":"693_CR61","first-page":"6371","volume":"159","author":"LM J\u00f8rgensen","year":"1997","unstructured":"J\u00f8rgensen, L. M., El Kholy, K., Damkj\u00e6r, K., Deis, A. & Schroll, M. [\u2018RAI\u2019\u2014 an international system for assessment of nursing home residents]. Ugeskr. L\u00e6ger 159, 6371\u20136376 (1997).","journal-title":"Ugeskr. L"},{"key":"693_CR62","first-page":"136","volume":"3","author":"SJSLHSSG Gudnason V","year":"1993","unstructured":"Gudnason V, S. J. S. L. H. S. S. G. Association of apolipoprotein E polymorphism with plasma levels of high density lipoprotein and lipoprotein(a), and effect of diet in healthy men and women. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES 3, 136\u2013141 (1993).","journal-title":"NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES"},{"key":"693_CR63","first-page":"155A","volume":"11","author":"A Levey","year":"2000","unstructured":"Levey, A., Greene, T., Kusek, J. & Beck, G. A simplified equation to predict glomerular filtration rate from serum creatinine. J. Am. Soc. Nephrol. 11, 155A (2000).","journal-title":"J. Am. Soc. Nephrol."},{"key":"693_CR64","doi-asserted-by":"crossref","first-page":"1843\u20131853","DOI":"10.2337\/db19-1070","volume":"69","author":"V Gudmundsdottir","year":"2020","unstructured":"Gudmundsdottir, V. et al. Circulating protein signatures and causal candidates for type 2 diabetes. Diabetes 69, 1843\u20131853 (2020).","journal-title":"Diabetes"},{"key":"693_CR65","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.molmed.2020.09.003","volume":"27","author":"JR Lamb","year":"2021","unstructured":"Lamb, J. R., Jennings, L. L., Gudmundsdottir, V., Gudnason, V. & Emilsson, V. It\u2019s in our blood: a glimpse of personalized medicine. Trends Mol. Med. 27, 20\u201330 (2021).","journal-title":"Trends Mol. Med."},{"key":"693_CR66","unstructured":"Gold, L. et al. Aptamer-based multiplexed proteomic technology for biomarker discovery. PLoS ONE 5, e15004 (2010)."},{"key":"693_CR67","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1021\/pr800545q","volume":"8","author":"MK Tuck","year":"2009","unstructured":"Tuck, M. K. et al. Standard operating procedures for serum and plasma collection: early detection research network consensus statement standard operating procedure integration working group. J. Proteome Res. 8, 113\u2013117 (2009).","journal-title":"J. Proteome Res."},{"key":"693_CR68","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s11357-023-00888-1","volume":"46","author":"ACE van Gennip","year":"2024","unstructured":"van Gennip, A. C. E. et al. Associations of plasma NfL, GFAP, and t-tau with cerebral small vessel disease and incident dementia: longitudinal data of the AGES-Reykjavik Study. Geroscience 46, 505\u2013516 (2024).","journal-title":"Geroscience"},{"key":"693_CR69","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.jalz.2014.01.001","volume":"10","author":"F Jessen","year":"2014","unstructured":"Jessen, F. et al. A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer\u2019s disease. Alzheimers Dement. 10, 844\u2013852 (2014).","journal-title":"Alzheimers Dement."},{"key":"693_CR70","first-page":"1394\u20131399","volume":"60","author":"OL Lopez","year":"2003","unstructured":"Lopez, O. L. et al. Risk factors for mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 2. Arch. Neurol. 60, 1394\u20131399 (2003).","journal-title":"Arch. Neurol."},{"key":"693_CR71","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/joim.12190","volume":"275","author":"RC Petersen","year":"2014","unstructured":"Petersen, R. C. et al. Mild cognitive impairment: a concept in evolution. J. Intern. Med. 275, 214\u2013228 (2014).","journal-title":"J. Intern. Med."},{"key":"693_CR72","doi-asserted-by":"crossref","first-page":"303\u2013308","DOI":"10.1001\/archneur.56.3.303","volume":"56","author":"RC Petersen","year":"1999","unstructured":"Petersen, R. C. et al. Mild cognitive impairment: clinical characterization and outcome. Arch. Neurol. 56, 303\u2013308 (1999).","journal-title":"Arch. Neurol."},{"key":"693_CR73","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack","year":"2018","unstructured":"Jack, C. R. et al. NIA\u2010AA Research Framework: toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement. 14, 535\u2013562 (2018).","journal-title":"Alzheimers Dement."},{"key":"693_CR74","doi-asserted-by":"crossref","first-page":"6891","DOI":"10.3390\/ijms23136891","volume":"23","author":"A Orellana","year":"2022","unstructured":"Orellana, A. et al. Establishing In-house cutoffs of CSF Alzheimer\u2019s disease biomarkers for the AT(N) stratification of the Alzheimer Center Barcelona cohort. Int. J. Mol. Sci. 23, 6891 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"693_CR75","unstructured":"Rodriguez-Gomez, O. et al. FACEHBI: a prospective study of risk factors, biomarkers and cognition in a cohort of individuals with subjective cognitive decline. study rationale and research protocols. J. Prev. Alzheimers Dis. 4, 100\u2013108 (2016)."},{"key":"693_CR76","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.jalz.2019.06.4950","volume":"15","author":"S Moreno-Grau","year":"2019","unstructured":"Moreno-Grau, S. et al. Genome-wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer\u2019s disease and three causality networks: the GR@ACE project. Alzheimers Dement. 15, 1333\u20131347 (2019).","journal-title":"Alzheimers Dement."},{"key":"693_CR77","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jalz.2011.07.004","volume":"8","author":"H Vanderstichele","year":"2012","unstructured":"Vanderstichele, H. et al. Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer\u2019s disease diagnosis: a consensus paper from the Alzheimer\u2019s Biomarkers Standardization Initiative. Alzheimers Dement. 8, 65\u201373 (2012).","journal-title":"Alzheimers Dement."},{"key":"693_CR78","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-22116-0","volume":"12","author":"J Candia","year":"2022","unstructured":"Candia, J., Daya, G. N., Tanaka, T., Ferrucci, L. & Walker, K. A. Assessment of variability in the plasma 7k SomaScan proteomics assay. Sci Rep. 12, 17147 (2022).","journal-title":"Sci Rep."},{"key":"693_CR79","unstructured":"Therneau, T. & Crowson, C. Using time dependent covariates and time dependent coefficients in the Cox model. Survival Vignettes http:\/\/lynchjim.com\/doc\/r-recommended\/library\/survival\/doc\/timedep.pdf (2014)."},{"key":"693_CR80","first-page":"1246\u20131254","volume":"74","author":"RF Gottesman","year":"2017","unstructured":"Gottesman, R. F. et al. Associations between midlife vascular risk factors and 25-year incident dementia in the Atherosclerosis Risk in Communities (ARIC) cohort. JAMA Neurol. 74, 1246\u20131254 (2017).","journal-title":"JAMA Neurol."},{"key":"693_CR81","first-page":"284\u2013287","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu, G., Wang, L. G., Han, Y. & He, Q. Y. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 16, 284\u2013287 (2012).","journal-title":"OMICS"},{"key":"693_CR82","doi-asserted-by":"publisher","unstructured":"Korotkevich, G. et al. Fast gene set enrichment analysis. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/060012 (2021).","DOI":"10.1101\/060012"},{"key":"693_CR83","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"693_CR84","first-page":"1318\u20131330","volume":"369","author":"F Aguet","year":"2020","unstructured":"Aguet, F. et al. The GTEx Consortium atlas of genetic regulatory effects across human tissues. Science 369, 1318\u20131330 (2020).","journal-title":"Science"},{"key":"693_CR85","doi-asserted-by":"crossref","first-page":"1260419","DOI":"10.1126\/science.1260419","volume":"347","author":"M Uhl\u00e9n","year":"2015","unstructured":"Uhl\u00e9n, M. et al. Proteomics. Tissue-based map of the human proteome. Science 347, 1260419 (2015).","journal-title":"Science"},{"key":"693_CR86","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/neup.12189","volume":"35","author":"TG Beach","year":"2015","unstructured":"Beach, T. G. et al. Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program. Neuropathology 35, 354\u2013389 (2015).","journal-title":"Neuropathology"},{"key":"693_CR87","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.3233\/JAD-179939","volume":"64","author":"DA Bennett","year":"2018","unstructured":"Bennett, D. A. et al. Religious Orders Study and Rush Memory and Aging Project. J. Alzheimers Dis. 64, S161\u2013S189 (2018).","journal-title":"J. Alzheimers Dis."},{"key":"693_CR88","doi-asserted-by":"crossref","first-page":"1880\u20131906","DOI":"10.1002\/sim.6835","volume":"35","author":"S Burgess","year":"2016","unstructured":"Burgess, S., Dudbridge, F. & Thompson, S. G. Combining information on multiple instrumental variables in Mendelian randomization: comparison of allele score and summarized data methods. Stat. Med. 35, 1880\u20131906 (2016).","journal-title":"Stat. Med."},{"key":"693_CR89","doi-asserted-by":"crossref","first-page":"D543","DOI":"10.1093\/nar\/gkab1038","volume":"50","author":"Y Perez-Riverol","year":"2022","unstructured":"Perez-Riverol, Y. et al. The PRIDE database resources in 2022: A hub for mass spectrometry-based proteomics evidences. Nucleic Acids Res. 50, D543\u2013D552 (2022).","journal-title":"Nucleic Acids Res."},{"key":"693_CR90","volume":"298","author":"S Zhang","year":"2022","unstructured":"Zhang, S. et al. Degradation and inhibition of epigenetic regulatory protein BRD4 exacerbate Alzheimer\u2019s disease-related neuropathology in cell models. J. Biol. Chem. 298, 101794 (2022).","journal-title":"J. Biol. Chem."},{"key":"693_CR91","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1038\/nn.4095","volume":"18","author":"E Korb","year":"2015","unstructured":"Korb, E., Herre, M., Zucker-Scharff, I., Darnell, R. B. & Allis, C. D. BET protein Brd4 activates transcription in neurons and BET inhibitor Jq1 blocks memory in mice. Nat. Neurosci. 18, 1464\u20131473 (2015).","journal-title":"Nat. Neurosci."},{"key":"693_CR92","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1073\/pnas.0308655100","volume":"101","author":"A Ho","year":"2004","unstructured":"Ho, A. & S\u00fcdhof, T. C. Binding of F-spondin to amyloid-\u03b2 precursor protein: a candidate amyloid-\u03b2 precursor protein ligand that modulates amyloid-\u03b2 precursor protein cleavage. Proc. Natl Acad. Sci. USA 101, 2548\u20132553 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"693_CR93","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1021\/cr00081a005","volume":"87","author":"DM Quinn","year":"1987","unstructured":"Quinn, D. M. Acetylcholinesterase: enzyme structure, reaction dynamics, and virtual transition states. Chem. Rev. 87, 955\u2013979 (1987).","journal-title":"Chem. Rev."},{"key":"693_CR94","doi-asserted-by":"crossref","unstructured":"Lu\u00eds, J. P., Sim\u00f5es, C. J. V. & Brito, R. M. M. The therapeutic prospects of targeting IL-1R1 for the modulation of neuroinflammation in central nervous system disorders. Int. J. Mol. Sci. 23, 1731 (2022).","DOI":"10.3390\/ijms23031731"},{"key":"693_CR95","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ebiom.2016.06.002","volume":"9","author":"F Letronne","year":"2016","unstructured":"Letronne, F. et al. ADAM30 downregulates APP-linked defects through cathepsin D activation in Alzheimer\u2019s disease. EBioMedicine 9, 278\u2013292 (2016).","journal-title":"EBioMedicine"},{"key":"693_CR96","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s40478-022-01356-1","volume":"10","author":"E Drummond","year":"2022","unstructured":"Drummond, E. et al. The amyloid plaque proteome in early onset Alzheimer\u2019s disease and Down syndrome. Acta Neuropathol. Commun. 10, 53 (2022).","journal-title":"Acta Neuropathol. Commun."},{"key":"693_CR97","doi-asserted-by":"crossref","first-page":"6427537","DOI":"10.1155\/2016\/6427537","volume":"2016","author":"I Leshchyns\u2019ka","year":"2016","unstructured":"Leshchyns\u2019ka, I. & Sytnyk, V. Synaptic cell adhesion molecules in Alzheimer\u2019s disease. Neural Plast. 2016, 6427537 (2016).","journal-title":"Neural Plast."},{"key":"693_CR98","first-page":"65","volume":"2","author":"M Wennstr\u00f6m","year":"2012","unstructured":"Wennstr\u00f6m, M. & Nielsen, H. M. Cell adhesion molecules in Alzheimer\u2019s disease. Degener. Neurol. Neuromuscul. Dis. 2, 65\u201377 (2012).","journal-title":"Degener. Neurol. Neuromuscul. Dis."},{"key":"693_CR99","doi-asserted-by":"crossref","first-page":"100372","DOI":"10.1016\/j.jbc.2021.100372","volume":"296","author":"W Kim","year":"2021","unstructured":"Kim, W., Watanabe, H., Lomoio, S. & Tesco, G. Spatiotemporal processing of neural cell adhesion molecules 1 and 2 by BACE1 in vivo. J. Biol. Chem. 296, 100372 (2021).","journal-title":"J. Biol. Chem."},{"key":"693_CR100","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40478-021-01119-4","volume":"9","author":"E Camporesi","year":"2021","unstructured":"Camporesi, E. et al. Neuroligin-1 in brain and CSF of neurodegenerative disorders: investigation for synaptic biomarkers. Acta Neuropathol. Commun. 9, 19 (2021).","journal-title":"Acta Neuropathol. Commun."},{"key":"693_CR101","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.bbrc.2015.08.107","volume":"466","author":"MC Dinamarca","year":"2015","unstructured":"Dinamarca, M. C., Di Luca, M., Godoy, J. A. & Inestrosa, N. C. The soluble extracellular fragment of neuroligin-1 targets A\u03b2 oligomers to the postsynaptic region of excitatory synapses. Biochem. Biophys. Res. Commun. 466, 66\u201371 (2015).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"693_CR102","doi-asserted-by":"crossref","first-page":"RP89453","DOI":"10.7554\/eLife.89453.3","volume":"12","author":"N Martin Flores","year":"2024","unstructured":"Martin Flores, N. et al. Downregulation of Dickkopf-3, a Wnt antagonist elevated in Alzheimer\u2019s disease, restores synapse integrity and memory in a disease mouse model. eLife 12, RP89453 (2024).","journal-title":"eLife"},{"key":"693_CR103","doi-asserted-by":"crossref","first-page":"e13430","DOI":"10.1111\/obr.13430","volume":"23","author":"HA Taylor","year":"2022","unstructured":"Taylor, H. A., Przemylska, L., Clavane, E. M. & Meakin, P. J. BACE1: more than just a \u03b2\u2010secretase. Obesity Rev. 23, e13430 (2022).","journal-title":"Obesity Rev."},{"key":"693_CR104","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.pbb.2013.03.003","volume":"107","author":"D Wang","year":"2013","unstructured":"Wang, D. et al. Cardiotrophin-1 (CTF1) ameliorates glucose-uptake defects and improves memory and learning deficits in a transgenic mouse model of Alzheimer\u2019s disease. Pharmacol. Biochem. Behav. 107, 48\u201357 (2013).","journal-title":"Pharmacol. Biochem. Behav."},{"key":"693_CR105","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13024-020-00377-5","volume":"15","author":"S Rayaprolu","year":"2020","unstructured":"Rayaprolu, S. et al. Flow-cytometric microglial sorting coupled with quantitative proteomics identifies moesin as a highly-abundant microglial protein with relevance to Alzheimer\u2019s disease. Mol. Neurodegener. 15, 28 (2020).","journal-title":"Mol. Neurodegener."},{"key":"693_CR106","doi-asserted-by":"crossref","first-page":"60\u201367","DOI":"10.1001\/jamaneurol.2015.3037","volume":"73","author":"H Zetterberg","year":"2016","unstructured":"Zetterberg, H. et al. Association of cerebrospinal fluid neurofilament light concentration with Alzheimer disease progression. JAMA Neurol. 73, 60\u201367 (2016).","journal-title":"JAMA Neurol."}],"updated-by":[{"DOI":"10.1038\/s43587-024-00718-9","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T00:00:00Z","timestamp":1726444800000}}],"container-title":["Nature Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43587-024-00693-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43587-024-00693-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43587-024-00693-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T20:12:09Z","timestamp":1729109529000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43587-024-00693-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,21]]},"references-count":106,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,10]]}},"alternative-id":["693"],"URL":"https:\/\/doi.org\/10.1038\/s43587-024-00693-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3706206\/v1","asserted-by":"object"}]},"ISSN":["2662-8465"],"issn-type":[{"value":"2662-8465","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,21]]},"assertion":[{"value":"11 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2024","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s43587-024-00718-9","URL":"https:\/\/doi.org\/10.1038\/s43587-024-00718-9","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"R.P., X.Q., N.F., L.L.J., A.P.O. and J.J.L. are employees and stockholders of Novartis. N.T.S. and A.I.L. are co-founders of Emtherapro. No other potential conflicts of interest relevant to this article were reported.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}